Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is prevalent in patients with type 2 diabetes. Here, we estimate the proportion of patients with type 2 diabetes that should be referred to hepatologists according to the European Association for the Study of the Liver (EASL)-European Association...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open Diabetes Res Care
Glavni autori: Ciardullo, Stefano, Muraca, Emanuele, Perra, Silvia, Bianconi, Eleonora, Zerbini, Francesca, Oltolini, Alice, Cannistraci, Rosa, Parmeggiani, Paola, Manzoni, Giuseppina, Gastaldelli, Amalia, Lattuada, Guido, Perseghin, Gianluca
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Clinical Care/Education/Nutrition
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039600/
https://ncbi.nlm.nih.gov/pubmed/32049637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000904
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items